Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
April-2021 Volume 21 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2021 Volume 21 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma

  • Authors:
    • Yuhan Zhang
    • Xinquan Gu
    • Fuquan Jiang
    • Pinghui Sun
    • Xu Li
  • View Affiliations / Copyright

    Affiliations: Department of Urology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, School of Public Health, Jilin University, Changchun, Jilin 130015, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Article Number: 331
    |
    Published online on: February 25, 2021
       https://doi.org/10.3892/ol.2021.12592
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Striatin‑4 (STRN4 or Zinedin) is a scaffolding protein belonging to the mammalian STRN family of proteins and consists of multiple functional signaling domains. Due to its numerous signaling complexes, STRN4 has been reported to be involved in the tumorigenesis of various cancer types, including colon cancer, liver cancer and prostate cancer. However, few studies on STRN4 have been conducted in bladder cancer, and its prognostic role in bladder cancer remains unknown. The present study aimed to investigate the expression levels of STRN4 in bladder transitional cell carcinoma and evaluate the prognostic role of STRN4. STRN4 expression in clinical specimens was analyzed using immunohistochemistry and reverse transcription‑quantitative PCR. It was demonstrated that STRN4 expression was significantly associated with clinical parameters such as tumor size, muscle invasion depth and pathological tumor grade. Abnormal STRN4 expression was typically associated with worse overall survival time and outcome when compared with the low STRN4 expression group. Using multivariate analysis, it was reported that STRN4 was an independent prognostic biomarker for survival time in bladder transitional cell carcinoma. Although the specific biological mechanisms of STRN4 in bladder cancer still remain to be elucidated, STRN4 expression could be a prognostic indicator in bladder cancer.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A and Bray F: Bladder cancer incidence and mortality: A global overview and recent trends. Eur Urol. 71:96–108. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Malmström PU: Why has the survival of patients with bladder cancer not improved? BJU Int. 101:267–269. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Benoist M, Gaillard S and Castets F: The striatin family: A new signaling platform in dendritic spines. J Physiol Paris. 99:146–153. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Tanabe O, Hirata D, Usui H, Nishito Y, Miyakawa T, Igarashi K and Takeda M: Fission yeast homologues of the B' subunit of protein phosphatase 2A: Multiple roles in mitotic cell division and functional interaction with calcineurin. Genes Cells. 6:455–473. 2001. View Article : Google Scholar : PubMed/NCBI

6 

Castets F, Rakitina T, Gaillard S, Moqrich A, Mattei MG and Monneron A: Zinedin, SG2NA, and striatin are calmodulin-binding, WD repeat proteins principally expressed in the brain. J Biol Chem. 275:19970–19977. 2000. View Article : Google Scholar : PubMed/NCBI

7 

Soni S, Jain BP, Gupta R, Dharavath S, Kar K, Komath SS and Goswami SK: Biophysical characterization of SG2NA variants and their interaction with DJ-1 and Calmodulin in vitro. Cell Biochem Biophys. 76:451–461. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Hwang J and Pallas DC: STRIPAK complexes: Structure, biological function, and involvement in human diseases. Int J Biochem Cell Biol. 47:118–148. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Castets F, Bartoli M, Barnier JV, Baillat G, Salin P, Moqrich A, Bourgeois JP, Denizot F, Rougon G, Calothy G and Monneron A: A novel calmodulin-binding protein, belonging to the WD-repeat family, is localized in dendrites of a subset of CNS neurons. J Cell Biol. 134:1051–1062. 1996. View Article : Google Scholar : PubMed/NCBI

10 

Pojoga LH, Coutinho P, Rivera A, Yao TM, Maldonado ER, Youte R, Adler GK, Williams J, Turchin A, Williams GH and Romero JR: Activation of the mineralocorticoid receptor increases striatin levels. Am J Hypertens. 25:243–249. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Lin L, Lo LH, Lyu Q and Lai KO: Determination of dendritic spine morphology by the striatin scaffold protein STRN4 through interaction with the phosphatase PP2A. J Biol Chem. 292:9451–9464. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Wong M, Hyodo T, Asano E, Funasaka K, Miyahara R, Hirooka Y, Goto H, Hamaguchi M and Senga T: Silencing of STRN4 suppresses the malignant characteristics of cancer cells. Cancer Sci. 105:1526–1532. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Reznickova E, Gucky T, Kovacova V, Ajani H, Jorda R and Krystof V: Activity of 2,6,9-trisubstituted purines as potent PDGFRα kinase inhibitors with antileukaemic activity. Eur J Med Chem. 182:1116632019. View Article : Google Scholar : PubMed/NCBI

14 

Jiang F, Zheng Q, Chang L, Li X, Wang X and Gu X: Pro-oncogene pokemon promotes prostate cancer progression by inducing STRN4 expression. J Cancer. 10:1833–1845. 2019. View Article : Google Scholar : PubMed/NCBI

15 

Cornejo KM, Rice-Stitt T and Wu CL: Updates in staging and reporting of genitourinary malignancies. Arch Pathol Lab Med. 144:305–319. 2020. View Article : Google Scholar : PubMed/NCBI

16 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Wang X, Jiang F, Song H, Li X, Xian J and Gu X: MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma. Biochem Biophys Res Commun. 470:620–626. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Li X, Jiang F, Wang X and Gu X: SPAG9 regulates HEF1 expression and drives EMT in bladder transitional cell carcinoma via rac1 signaling pathway. Am J Cancer Res. 8:2467–2480. 2018.PubMed/NCBI

19 

Du B, Liu S, Cui C, Wang S and Cui W: Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific (1rs8418532). J Diabetes. 5:291–299. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM, Hernandez V, Espinos EL, Dunn J, Rouanne M, et al: Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 71:462–475. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Comperat EM, Hernandez V, Kaasinen E, Palou J, Roupret M, et al: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol. 71:447–461. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Gakis G, Witjes JA, Comperat E, Cowan NC, De Santis M, Lebret T, Ribal MJ and Sherif AM; European Association of Urology, : EAU guidelines on primary urethral carcinoma. Eur Urol. 64:823–830. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Goudreault M, D'Ambrosio LM, Kean MJ, Mullin MJ, Larsen BG, Sanchez A, Chaudhry S, Chen GI, Sicheri F, Nesvizhskii AI, et al: A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol Cell Proteomics. 8:157–171. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Gordon J, Hwang J, Carrier KJ, Jones CA, Kern QL, Moreno CS, Karas RH and Pallas DC: Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3. BMC Biochemistry. 12:542011. View Article : Google Scholar : PubMed/NCBI

25 

Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, et al: Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 76:42–51. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Baillat G, Moqrich A, Castets F, Baude A, Bailly Y, Benmerah A and Monneron A: Molecular cloning and characterization of Phocein, a protein found from the golgi complex to dendritic spines. Mol Biol Cell. 12:663–673. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Zheng Y, Liu B, Wang L, Lei H, Pulgar Prieto KD and Pan D: Homeostatic control of Hpo/MST kinase activity through autophosphorylation-dependent recruitment of the STRIPAK PP2A phosphatase complex. Cell Rep. 21:3612–3623. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Wagh V, Doss MX, Sabour D, Niemann R, Meganathan K, Jagtap S, Gaspar JA, Ardestani MA, Papadopoulos S, Gajewski M, et al: Fam40b is required for lineage commitment of murine embryonic stem cells. Cell Death Dis. 5:e13202014. View Article : Google Scholar : PubMed/NCBI

29 

Shi Z, Jiao S and Zhou Z: STRIPAK complexes in cell signaling and cancer. Oncogene. 35:4549–4557. 2016. View Article : Google Scholar : PubMed/NCBI

30 

Madsen CD, Hooper S, Tozluoglu M, Bruckbauer A, Fletcher G, Erler JT, Bates PA, Thompson B and Sahai E: STRIPAK components determine mode of cancer cell migration and metastasis. Nat Cell Biol. 17:68–80. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Chen M, Zhang H, Shi Z, Li Y, Zhang X, Gao Z, Zhou L, Ma J, Xu Q, Guan J, et al: The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer. J Biol Chem. 293:14455–14469. 2018. View Article : Google Scholar : PubMed/NCBI

32 

Wahlin S, Nodin B, Leandersson K, Boman K and Jirstrom K: Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: A comparative study of transurethral resection and cystectomy specimens. Oncoimmunology. 8:e16441082019. View Article : Google Scholar : PubMed/NCBI

33 

Lionello M, Bertolin A, Nardello E, Giacomelli L, Canal F, Rizzotto G, Marioni G and Lucioni M: Could the infiltration of the thyroarytenoid muscle define the pT2 glottic carcinoma? Head Neck. 41:3639–3646. 2019. View Article : Google Scholar : PubMed/NCBI

34 

Botling J, Lamarca A, Bajic D, Norlen O, Lonngren V, Kjaer J, Eriksson B, Welin S, Hellman P, Rindi G, et al: High-grade progression confers poor survival in pancreatic neuroendocrine tumors. Neuroendocrinology. 110:891–898. 2020. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang Y, Gu X, Jiang F, Sun P and Li X: Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma. Oncol Lett 21: 331, 2021.
APA
Zhang, Y., Gu, X., Jiang, F., Sun, P., & Li, X. (2021). Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma. Oncology Letters, 21, 331. https://doi.org/10.3892/ol.2021.12592
MLA
Zhang, Y., Gu, X., Jiang, F., Sun, P., Li, X."Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma". Oncology Letters 21.4 (2021): 331.
Chicago
Zhang, Y., Gu, X., Jiang, F., Sun, P., Li, X."Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma". Oncology Letters 21, no. 4 (2021): 331. https://doi.org/10.3892/ol.2021.12592
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Gu X, Jiang F, Sun P and Li X: Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma. Oncol Lett 21: 331, 2021.
APA
Zhang, Y., Gu, X., Jiang, F., Sun, P., & Li, X. (2021). Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma. Oncology Letters, 21, 331. https://doi.org/10.3892/ol.2021.12592
MLA
Zhang, Y., Gu, X., Jiang, F., Sun, P., Li, X."Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma". Oncology Letters 21.4 (2021): 331.
Chicago
Zhang, Y., Gu, X., Jiang, F., Sun, P., Li, X."Altered expression of striatin‑4 is associated with poor prognosis in bladder transitional cell carcinoma". Oncology Letters 21, no. 4 (2021): 331. https://doi.org/10.3892/ol.2021.12592
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team